Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -2.89 |
| peg ratio | -0.03 |
| price to book ratio | 6.45 |
| price to sales ratio | 12,837.37 |
| enterprise value multiple | -5.25 |
| price fair value | 6.45 |
profitability ratios | |
|---|---|
| gross profit margin | 39.88% |
| operating profit margin | -287067.49% |
| pretax profit margin | -274861.24% |
| net profit margin | -274861.24% |
| return on assets | -162.59% |
| return on equity | -142.95% |
| return on capital employed | -232.86% |
liquidity ratio | |
|---|---|
| current ratio | 3.69 |
| quick ratio | 3.69 |
| cash ratio | 3.44 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 108,978.60 |
| cash conversion cycle | -108,978.60 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -2,805.24 |
cash flow ratios | |
|---|---|
| free cash flow per share | -5.67 |
| cash per share | 3.95 |
| operating cash flow per share | -5.67 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -2,805.24 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -1,924.18 |
Frequently Asked Questions
Cadrenal Therapeutics, Inc. Common Stock (CVKD) published its most recent earnings results on 07-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Cadrenal Therapeutics, Inc. Common Stock (NASDAQ:CVKD)'s trailing twelve months ROE is -142.95%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Cadrenal Therapeutics, Inc. Common Stock (CVKD) currently has a ROA of -162.59%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
CVKD reported a profit margin of -274861.24% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.69 in the most recent quarter. The quick ratio stood at 3.69, with a Debt/Eq ratio of 0.00.